NO20064359L - Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator - Google Patents

Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator

Info

Publication number: NO20064359L
Authority: NO; Norway
Prior art keywords: solution formulation; stable pharmaceutical; pharmaceutical solution; hydroxy; pressurized dosage
Prior art date: 2004-02-27

Application number

NO20064359A

Other languages

English (en)

Norwegian (no)

Inventor

Maurizio Delcanale

David Lewis

David Ganderton

Brian John Meakin

Fausto Pivetti

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-27

Filing date

2006-09-26

Publication date

2006-09-26

2004-05-13 Priority claimed from EP04011424A external-priority patent/EP1595531A1/fr

2006-09-26 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2006-09-26 Publication of NO20064359L publication Critical patent/NO20064359L/no

Links

238000009472 formulation Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
239000003186 pharmaceutical solution Substances 0.000 title 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
239000000443 aerosol Substances 0.000 abstract 2
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 abstract 1
IHOXNOQMRZISPV-YJYMSZOUSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]azaniumyl]ethyl]-2-oxo-1h-quinolin-8-olate Chemical compound C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2 IHOXNOQMRZISPV-YJYMSZOUSA-N 0.000 abstract 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
-1 hydrogen fluoro alkane Chemical class 0.000 abstract 1
239000003380 propellant Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Dispersion Chemistry (AREA)
Inorganic Chemistry (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Mechanical Engineering (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20064359A 2004-02-27 2006-09-26 Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator NO20064359L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US54779804P	2004-02-27	2004-02-27
EP04011424A EP1595531A1 (fr)	2004-05-13	2004-05-13	Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression
PCT/EP2005/002042 WO2005084640A1 (fr)	2004-02-27	2005-02-25	Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises

Publications (1)

Publication Number	Publication Date
NO20064359L true NO20064359L (no)	2006-09-26

Family

ID=34921308

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064359A NO20064359L (no)	2004-02-27	2006-09-26	Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator

Country Status (5)

Country	Link
US (1)	US20070025920A1 (fr)
KR (1)	KR20070000476A (fr)
IL (1)	IL177103A0 (fr)
MA (1)	MA28485B1 (fr)
NO (1)	NO20064359L (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0510852A (pt) *	2004-05-13	2007-11-27	Chiesi Farma Spa	produtos medicinais em formulação aerossol com estabilidade quìmica aprimorada
US8227027B2 (en) *	2007-12-07	2012-07-24	Presspart Gmbh & Co. Kg	Method for applying a polymer coating to an internal surface of a container
US8532271B2 (en) *	2009-01-21	2013-09-10	Chung-Yu Lin	Cybercrime detecting and preventing method and system established by telephone number code, authorization codes and source identification code

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8334494D0 (en) *	1983-12-24	1984-02-01	Tanabe Seiyaku Co	Carbostyril derivatives
ATE177941T1 (de) *	1992-12-09	1999-04-15	Boehringer Ingelheim Pharma	Stabilisierte medizinische aerosollösungen
HU219900B (hu) *	1995-04-14	2001-09-28	Glaxo Wellcome Inc.	Mért dózist adagoló inhalálóberendezés
HU219899B (hu) *	1995-04-14	2001-09-28	Glaxo Wellcome Inc.	Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban
ES2234266T3 (es) *	1998-07-24	2005-06-16	Jago Research Ag	Formulaciones medicas para aerosoles.
DE19847969A1 (de) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Lagerfähig flüssige Formulierung mit Formoterol
IT1303788B1 (it) *	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
AU2000250701B2 (en) *	2000-05-22	2004-07-01	Chiesi Farmaceutici S.P.A.	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
ES2342463T3 (es) *	2002-03-01	2010-07-07	Chiesi Farmaceutici S.P.A.	Formulacion superfina de formoterol.
EP1340492A1 (fr) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
EP1595531A1 (fr) *	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression

2005
- 2005-02-25 KR KR1020067015964A patent/KR20070000476A/ko not_active Ceased
2006
- 2006-07-26 IL IL177103A patent/IL177103A0/en unknown
- 2006-08-25 US US11/467,515 patent/US20070025920A1/en not_active Abandoned
- 2006-09-22 MA MA29342A patent/MA28485B1/fr unknown
- 2006-09-26 NO NO20064359A patent/NO20064359L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HK1103280A1 (zh)	2007-12-14
MA28485B1 (fr)	2007-03-01
US20070025920A1 (en)	2007-02-01
KR20070000476A (ko)	2007-01-02
IL177103A0 (en)	2006-12-10

Similar Documents

Publication	Publication Date	Title
US8476259B2 (en)	2013-07-02	Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
WO2007095043A3 (fr)	2007-12-21	Formulations pharmaceutiques
MX2025001619A (es)	2025-03-07	Inhibidor de pde4b y uso del mismo
EA200601578A1 (ru)	2007-02-27	Стабильные фармацевтические растворы для дозированных ингаляторов под давлением
CA2492976A1 (fr)	2004-03-18	Solution destinee a une application ungueale et peri-ungueale
GEP20063876B (en)	2006-07-10	Pressurised metered dose inhalers containing solutions of beta-2 agonists
WO2007014673A3 (fr)	2007-07-19	Formulations pharmaceutiques comprenant un agoniste beta2 a longue duree d'action administrees par nebulisation
NO20080220L (no)	2008-04-21	Formuleringer med hoy medikament belastning og doseringsformer
WO2009008487A1 (fr)	2009-01-15	Préparation enrobée
SG183006A1 (en)	2012-08-30	Pharmaceutical composition for topical application of poorly soluble compounds
CA2488422A1 (fr)	2004-08-12	Composition medicinale solide, stabilisee, a base de ramosetron, pour administration orale
NO20064359L (no)	2006-09-26	Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator
NO20074854L (no)	2007-09-24	Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel
EP4461364A3 (fr)	2024-11-27	Formulation de laquinimod à usage oculaire
KR102538216B9 (ko)	2023-09-07	폴리감마글루탐산을 유효성분으로 포함하는 코로나바이러스(SARS-CoV-2) 감염질환의 예방, 경감 또는 치료용 약학적 조성물
AR122989A1 (es)	2022-10-19	Formulación farmacéutica tópica estable que contiene un inmunosupresor para el tratamiento de afecciones dermatológicas
BRPI0417011A (pt)	2007-02-21	composições compreendendo compostos orgánicos
JOP20230297A1 (ar)	2023-11-19	تركيبة مُعَلَّق مائي توخذ عن طريق الفم تشتمل على مُركَّب كاربامات
UA88894C2 (ru)	2009-12-10	Стабильные фармацевтические композиции в виде растворов для ингаляторов с дозатором, которые находятся под давлением
TH76283A (th)	2006-03-09	สูตรสารละลายยาที่เสถียรสำหรับอุปกรณ์การพ่นฝอยละอองยา
EP2351569B1 (fr)	2012-08-22	Fasudil dans des thérapies combinées pour le traitement de l'hypertension artérielle pulmonaire
US8697712B2 (en)	2014-04-15	Presentation of an antiviral pharmaceutical composition
MX2025010806A (es)	2025-10-01	Formulacion farmaceutica topica que comprende inhibidor de quinasa
WO2011154830A3 (fr)	2012-03-01	Forme pharmaceutique d'inhibiteurs de la phosphodiestérase pour l'adminsitration par voie transmucosale
AR048418A1 (es)	2006-04-26	Formulaciones de soluciones medicinales estables para inhaladores de cartucho presurizados

Legal Events

Date	Code	Title	Description
2011-09-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application